Ekso Bionics Holdings Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
72
- Stock Symbol
-
EKSO
- Investments
-
5
- Share Price
-
$0.65
- (As of Friday Closing)
Ekso Bionics Holdings General Information
Description
Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets. The wearable exoskeletons are to be worn over clothes and controlled by a trained operator to augment human strength, endurance, and mobility. The company's segments are EksoHealth and EksoWorks. All of the company's operations are held in the United States. The EksoHealth segment which derives majority revenue designs, engineers, manufactures and sells exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The regions company operates in are the Americas, EMEA, and APAC.
Contact Information
Website
www.eksobionics.comCorporate Office
- 101 Glacier Point
- Suite A
- San Rafael, CA 94901
- United States
Corporate Office
- 101 Glacier Point
- Suite A
- San Rafael, CA 94901
- United States
Ekso Bionics Holdings Stock Performance
As of 17-Jan-2025, Ekso Bionics Holdings’s stock price is $0.65. Its current market cap is $14.3M with 21.5M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.65 | $0.69 | $0.50 - $2.50 | $14.3M | 21.5M | 1.01M | -$0.64 |
Ekso Bionics Holdings Financials Summary
As of 30-Sep-2024, Ekso Bionics Holdings has a trailing 12-month revenue of $17.7M.
|
In Thousands, USD |
TTM 30-Sep-2024 | FY 2023 31-Dec-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 |
|---|---|---|---|---|
| EV | 25,797 | 33,134 | (10,134) | (7,516) |
| Revenue | 17,682 | 18,279 | 12,912 | 11,246 |
| EBITDA | (9,213) | (13,198) | (14,037) | (8,628) |
| Net Income | (11,131) | (15,198) | (15,080) | (9,764) |
| Total Assets | 29,209 | 28,918 | 40,903 | 49,166 |
| Total Debt | 6,346 | 7,168 | 7,505 | 2,222 |
Ekso Bionics Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Ekso Bionics Holdings Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Ekso Bionics Holdings Comparisons
Industry
Financing
Details
Ekso Bionics Holdings Competitors (5)
One of Ekso Bionics Holdings’s 5 competitors is Lifeward, a Formerly VC-backed company based in Yokneam Illit, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Lifeward | Formerly VC-backed | Yokneam Illit, Israel | ||||
| Bionik Laboratories | Formerly PE-Backed | Toronto, Canada | ||||
| Philips | Corporation | Amsterdam, Netherlands | ||||
| Tyromotion | Private Equity-Backed | Graz, Austria | ||||
| SuitX | Formerly PE-Backed | Emeryville, CA |
Ekso Bionics Holdings Patents
Ekso Bionics Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4308049-A1 | Control method for a powered knee ankle foot orthosis | Pending | 15-Mar-2021 | ||
| US-20240148522-A1 | Control method for a powered knee ankle foot orthosis | Pending | 15-Mar-2021 | ||
| US-D972153-S1 | Movement assistance device for an orthosis | Active | 09-Dec-2020 | ||
| US-20220387196-A1 | Biomechanical motion device for human gait load replication | Pending | 20-Oct-2020 | ||
| US-20220313534-A1 | Two stage actuator for powered mobilitity assistance devices with electrical isolation | Pending | 14-Aug-2019 | A61H3/00 |
Ekso Bionics Holdings Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Ekso Bionics Holdings Investments & Acquisitions (5)
Ekso Bionics Holdings’s most recent deal was a Merger/Acquisition with Indego for . The deal was made on 05-Dec-2022.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Indego | 05-Dec-2022 | Merger/Acquisition | Medical Supplies | ||
| Exoskeleton Intelligent Robotics | 30-Jan-2019 | Joint Venture | Therapeutic Devices | ||
| Equipois (Gravity Balancing Arm Technology) | 04-Dec-2015 | Corporate Asset Purchase | Buildings and Property | ||
| Equipois | 01-Dec-2015 | Merger/Acquisition | Other Commercial Products | ||
| PN Med Group | 15-Jan-2014 | Merger/Acquisition | Distributors (Healthcare) |
Ekso Bionics Holdings ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Healthcare
Industry
Rank
Percentile
Medical Distribution
Subindustry
Rank
Percentile
Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Equipois | Manchester, NH | 2007 |
Ekso Bionics Holdings FAQs
-
When was Ekso Bionics Holdings founded?
Ekso Bionics Holdings was founded in 2005.
-
Where is Ekso Bionics Holdings headquartered?
Ekso Bionics Holdings is headquartered in San Rafael, CA.
-
What is the size of Ekso Bionics Holdings?
Ekso Bionics Holdings has 72 total employees.
-
What industry is Ekso Bionics Holdings in?
Ekso Bionics Holdings’s primary industry is Therapeutic Devices.
-
Is Ekso Bionics Holdings a private or public company?
Ekso Bionics Holdings is a Public company.
-
What is Ekso Bionics Holdings’s stock symbol?
The ticker symbol for Ekso Bionics Holdings is EKSO.
-
What is the current stock price of Ekso Bionics Holdings?
As of 17-Jan-2025 the stock price of Ekso Bionics Holdings is $0.65.
-
What is the current market cap of Ekso Bionics Holdings?
The current market capitalization of Ekso Bionics Holdings is $14.3M.
-
What is Ekso Bionics Holdings’s current revenue?
The trailing twelve month revenue for Ekso Bionics Holdings is $17.7M.
-
Who are Ekso Bionics Holdings’s competitors?
Lifeward, Bionik Laboratories, Philips, Tyromotion, and SuitX are competitors of Ekso Bionics Holdings.
-
What is Ekso Bionics Holdings’s annual earnings per share (EPS)?
Ekso Bionics Holdings’s EPS for 12 months was -$0.64.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
